$ELVR

Elevra Lithium Completes Binding Supply Agreement with Mangrove Lithium

Elevra Lithium (ASX:ELV, NASDAQ:ELVR) finalized a binding supply agreement with Mangrove Lithium for long-term spodumene concentrate supply from its North American Lithium facility in Québec. The deal follows a previous MoU and includes a price floor above production costs and no price ceiling. Elevra aims to avoid seaborne freight costs by supplying a local customer.

Original reporting
Published Aug 21, 2026, 1:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 21, 2026, 2:26 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$ELVR
Bullish
high confidence
Mentioned
$ELVR
Relevance
7/10
alphai data visualization · based on leaderpost.com
Decision brief

The 30-second read

$ELVRBullishMed
01

Why it matters

The binding agreement secures a key off‑taker, reduces logistics costs, and sets a price floor above production cost, likely improving Elevra's margin profile and cash flow outlook.

02

Market read

The deal is material for Elevra and may influence investor sentiment toward junior lithium producers.

03

What to watch

Execution risk at the Québec plant and potential regulatory changes in Canada.

Relevance 7/10Novelty 8/10Timing: released today

Background

Elevra Lithium (ASX:ELV, NASDAQ:ELVR) is a North American lithium producer developing the NAL project in Québec. Mangrove Lithium plans a 20,000‑tonne per annum LCE conversion facility in Eastern Canada.

Company-level read

Ticker impact

$ELVRBullishHigh confidence
Context

Elevra Lithium announced a binding supply agreement for spodumene concentrate with Mangrove Lithium, securing a long‑term local customer for its North American Lithium project.

Expected impact

Expect modest upside as the deal de‑ricks margin risk; price may rise 2‑4% on news.

Evidence & confidence

First‑time disclosure of a material supply contract with clear financial upside; market will price in improved cash flow.

Market effects

Strengthens the North American lithium supply chain, may benefit peers with similar projects.

Positive for Australian‑listed lithium producers with US exposure.

Adds confidence to the broader lithium market amid growing EV demand.

Counterpoint

If the price floor is set too low relative to future spot prices, upside could be limited.

Key entities

  • Elevra Lithium Limited

    North American lithium producer listed on NASDAQ (ELVR) and ASX.

  • Mangrove Lithium

    Lithium developer planning a conversion facility in Eastern Canada.

Related articles

$ELVRMed

Elevra Lithium Limited: Elevra Lithium Completes Binding Supply Agreement with Mangrove Lithium

Elevra Lithium (ASX:ELV; NASDAQ:ELVR) signed a binding 7-year spodumene supply deal with Mangrove Lithium, extendable for another 7 years. The agreement covers 122,000 tonnes annually, with a floor price above Elevra's production costs and no ceiling. Both companies are backed by the Canada Growth Fund, aiming to strengthen Canada's lithium supply chain. Mangrove must reach a final investment decision by 2028.

$ELVRMed

Elevra Lithium Q4 Earnings Call Highlights

Elevra Lithium (NASDAQ:ELVR) reported June-quarter revenue of $31 billion and average realized price of $921 per tonne, with unit operating costs of $907 per tonne. Full-year unit operating costs were $853 per tonne, below revised guidance of $860 to $880. The company raised $207 million net from equity and $145 million CAD via convertible notes, funded NAL expansion, and expects higher shipping volumes.

$ELVRMed

Elevra Lithium Quarterly Activities Report

Elevra Lithium Limited (ASX: ELV, NASDAQ: ELVR) reported June 2026 quarter results for North American Lithium. Ore mined was 372,938 wmt, process plant utilisation 92%, lithium recoveries 71%, and spodumene concentrate 54,479 dmt. Spodumene sales were 33,977 dmt at US$921/dmt for US$31m revenue. Elevra also announced a US$196m placement plus US$102m convertible notes to fund the NAL expansion, and said cash was US$255m at quarter end.

$ELVRMed

Elevra Lithium Limited (ASX:ELV) EGM - Chair Address and EGM Slides

Elevra Lithium Limited (ASX:ELV, NASDAQ:ELVR, OTC:SYAXF) said at its 2026 EGM it plans a three-stage North American Lithium brownfield expansion to raise annual spodumene concentrate capacity to 338ktpa by 2029. It targets 4,500 tpd milling throughput in Stage 1, 6,500 tpd by 2028 in Stage 2, and lower unit costs in Stage 3. The A$508M funding package includes A$275M equity, A$146M convertible notes from Canada Growth Fund, and about A$87M net proceeds from divesting Ghana’s Ewoyaa. The updated

$ELVRMed

Elevra Lithium Limited (ASX:ELV) ASX CEO Connect Presentation

Elevra Lithium Limited (ASX:ELV) released its June 2026 investor presentation on supplying lithium in North America. For YTD FY26, it reported 143,489 dmt spodumene concentrate produced, 147,517 dmt sold, 66% recovery, US$167m revenue and unit operating costs of US$840/t. It cited net cash of US$321m and ~US$1,887m market cap. It also outlined resources of 229Mt at 1.14% Li2O and reserves of 106Mt at 1.15% Li2O, plus growth plans including NAL expansion with staged production from CY27.